17
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T78685 | Polymyxin B | ||
Polymyxin B, an antibiotic, combats Gram-negative infections through high-affinity binding to the bacterial wall's lipopolysaccharides (LPS), neutralizing endotoxin effects and inducing bacterial cell death by enhancing ... | |||
TP1341L | Polymyxin B nonapeptide acetate | Polymyxin B nonapeptide acetate(86408-36-8 free base) | Antibacterial , Antibiotic |
Polymyxin B nonapeptide acetate is a cationic cyclic peptide. Polyxin B nonapeptide is a derivative produced by enzymatic cleavage of polyxin B. Compared with polyxin B, polyxin B nonapeptide has low toxicity, lacks bact... | |||
T1100 | Polymyxin B Sulfate | Aerosporin,PMB,Polymyxin B sulphate,Polymyxin B sulfate (1404-26-8 free base),Poly-RX | Antibacterial , Antibiotic |
Polymyxin B Sulfate (Poly-RX) is a mixture of polymyxins B1 and B2, obtained from Bacillus polymyxa strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Po... | |||
TP1341 | Polymyxin B nonapeptide | ||
Polymyxin B nonapeptide, a cationic cyclic peptide derived by enzymatic processing from the naturally occurring peptide polymyxin B, is able to increase the permeability of the outer membrane of Gram-negative bacteria to... | |||
T25971 | Polymyxin B2 | Polymyxin-B2,PolymyxinB2 | |
Polymyxin B2 is an antibiotic primarily utilized for resistant Gram-negative infections. It is derived from the bacterium Bacillus polymyxa. | |||
T25970 | Polymyxin B1-i | ||
Polymyxin B1-i is a polypeptide antibiotic. | |||
T64687 | Polymyxin B nonapeptide TFA | ||
Polymyxin B nonapeptide TFA is a useful organic compound for research related to life sciences and the catalog number is T64687. | |||
T12518 | Polymyxin B1 | Others | |
Polymyxin B1 is a potent antimicrobial lipopeptide first derived from Bacilus polymyxa. Polymyxin B1 has the potential for multidrug-resistant Gram-negative bacterial infections treatment. | |||
T67912 | PA3552-IN-1 | ||
PA3552-IN-1 is an antibiotic adjuvant that can reduce the expression of PA3552 and restore the sensitivity of MDR Pseudomonas aeruginosa DK2 strain to Polymyxin B. | |||
T12992 | SPR741 acetate | SPR741 acetate,NAB741 acetate,SPR741 acetate (1179330-52-9 free base) | Antibacterial |
SPR741 acetate is a cationic peptide derived from polymyxin B. It exhibits antimicrobial activity against gram-negative bacteria by inhibiting severe gram-negative bacterial sensory by increasing the permeability of the ... | |||
T83903 | Polymyxin B2 sulfate | ||
Polymyxin B2, a significant component of polymyxin B, is an antibiotic cationic lipopeptide initially derived from B. polymyxa. This compound effectively inhibits P. aeruginosa, A. baumannii, K. pneumoniae, and E. cloaca... | |||
TP1089 | SPR741 TFA (1179330-52-9 free base) | NAB741 TFA,SPR741 TFA | |
SPR741 TFA (NAB741 TFA) is a cationic peptide derived from polymyxin B and is a potentiator molecule. | |||
TP1090 | SPR741 | NAB741 | |
SPR741, formerly NAB741 (12), is a cationic peptide derived from polymyxin B and is one such potentiator molecule that is under development for the treatment of serious Gram-negative bacterial infections. | |||
T83902 | Polymyxin E1 sulfate | Colistin A sulfate | |
Polymyxin E1, a peptide antibiotic and key component of the cationic lipopeptide antibiotic colistin, was initially extracted from B. polymyxa. It demonstrates effectiveness against P. aeruginosa and E. coli, with minimu... | |||
T83904 | Polymyxin E2 sulfate | Colistin B sulfate | |
Polymyxin E2, a key component of the cationic lipopeptide antibiotic colistin, was originally derived from B. polymyxa and serves as a peptide antibiotic. It exhibits effective antibacterial activity against the plant pa... | |||
T35742 | IKD-8344 | ||
IKD-8344 is a macrocyclic dilactone originally isolated from an actinomycete species and has diverse biological activities, including anticancer, antimicrobial, and anthelmintic properties.1,2,3 It is cytotoxic to L5178Y... | |||
T75994 | SPR741 TFA | ||
SPR741 TFA (NAB741 TFA), a cationic peptide derived from polymyxin B, acts as a potentiator molecule that enhances the permeability of Gram-negative bacteria's outer membrane, thereby facilitating the treatment of severe... |